Utama › Penyakit Alzheimer › Florida › West Palm Beach
Kajian klinikal Penyakit Alzheimer di West Palm Beach, FL
13 kajian untuk Penyakit Alzheimer sedang mencari peserta di lokasi dalam dan sekitar West Palm Beach (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Mengambil pesertaFasa 2
- Clinical Site, West Palm Beach
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Mengambil pesertaFasa 3
- Premiere Research Institute at Palm Beach Neurology, PA, West Palm Beach
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Mengambil pesertaFasa 2
- Palm Beach Neurology, West Palm Beach
- JEM Research Institute, Atlantis · 9 mi jauh
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Mengambil pesertaFasa 2
- JEM Research Institute, Atlantis · 9 mi jauh
- Alzheimer's Research and Treatment Center - Wellington, Wellington · 12 mi jauh
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Mengambil pesertaFasa 3
- JEM Research LLC, Atlantis · 9 mi jauh
- Alzheimer?s Research and Treatment Center, Wellington · 12 mi jauh
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Mengambil pesertaFasa 1/2
- Alzheimer's Research And Treatment Center - Wellington /ID# 277749, Wellington · 12 mi jauh
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Mengambil pesertaFasa 3
- Alzheimer's Research and Treatment Center, Wellington · 12 mi jauh
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Mengambil pesertaFasa 2
- JEM Research Institute ( Site 1046), Atlantis · 9 mi jauh
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Mengambil pesertaFasa 1
- Alzheimer's Research and Treatment Center (Wellington), Wellington · 12 mi jauh
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Mengambil pesertaFasa 3
- JEM Research Institute, Atlantis · 9 mi jauh
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Mengambil pesertaFasa 3
- Finlay Medical Research, Greenacres City · 8 mi jauh
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Mengambil pesertaFasa 2
- Jem Research Institute, Atlantis · 9 mi jauh
- Alzheimers Research Treatment Ctr, Wellington · 12 mi jauh
- Alzheimers Research Treatment Ctr, Wellington · 12 mi jauh
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- JEM Research Institute, Atlantis · 9 mi jauh
Kajian Penyakit Alzheimer di bandar lain
- Boston, MA26 kajian
- Orlando, FL25 kajian
- St. Louis, MO22 kajian
- New York City, NY21 kajian
- Miami, FL20 kajian
- Tampa, FL17 kajian
- Atlanta, GA16 kajian
- The Villages, FL15 kajian
- Philadelphia, PA15 kajian
- Phoenix, AZ15 kajian
- Indianapolis, IN14 kajian
- Los Angeles, CA14 kajian
Kajian lain di West Palm Beach
- Kanser Paru-paru Bukan Sel Kecil13 kajian
- Obesiti11 kajian
- Kanser Ovari11 kajian
- Berat Badan Berlebihan9 kajian
- Kanser Endometrium8 kajian
- Skizofrenia7 kajian
- Kegagalan Jantung7 kajian
- Diabetes Jenis 27 kajian
- Penyakit Kardiovaskular7 kajian
- Gangguan Depresi Major7 kajian
- COPD6 kajian
- HIV6 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.